General Information of Drug Transporter (DT)
DT ID DTD0282 Transporter Info
Gene Name SLC33A1
Transporter Name Acetyl-coenzyme A transporter 1
Gene ID
9197
UniProt ID
O00400
Post-Translational Modification of This DT
Overview of SLC33A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC33A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

103

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC33A1 Asparagine 103 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC33A1 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

487

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC33A1 Cystine 487 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC33A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Serine 2 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC33A1 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

6

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Serine 6 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC33A1 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

20

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Serine 20 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC33A1 [6] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

22

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Serine 22 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC33A1 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

38

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Serine 38 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC33A1 [3] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

4

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Threonine 4 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC33A1 [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

367

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Threonine 367 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC33A1 [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

375

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Threonine 375 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC33A1 [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

366

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Tyrosine 366 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC33A1 [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

377

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Tyrosine 377 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC33A1 [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

382

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC33A1 Tyrosine 382 has the potential to affect its expression or activity.

S-palmitoylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC33A1 [12]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

496

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-palmitoylation at SLC33A1 Cystine 496 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC33A1 [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

63

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC33A1 Lysine 63 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC33A1 [14] , [15]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

135

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC33A1 Lysine 135 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC33A1 [16]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

288

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC33A1 Lysine 288 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC33A1 [16]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

497

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC33A1 Lysine 497 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC33A1 [16]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

534

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC33A1 Lysine 534 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC33A1 [16]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

544

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC33A1 Lysine 544 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ACATN_HUMAN)
2 Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
3 CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
4 Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
5 Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics. Proteomics. 2015 Jan;15(2-3):340-55.
6 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
7 Phosphoproteome Profiling Reveals Molecular Mechanisms of Growth-Factor-Mediated Kinase Inhibitor Resistance in EGFR-Overexpressing Cancer Cells. J Proteome Res. 2016 Dec 2;15(12):4490-4504.
8 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
9 Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
10 Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
11 Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
12 Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
13 Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.
14 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
15 Global identification of modular cullin-RING ligase substrates. Cell. 2011 Oct 14;147(2):459-74.
16 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.